1. Inhibition of Tumor Growth and Metastasis by Targeting Tumor-Associated Angiogenesis with Antagonists to the Receptors of Vascular Endothelial Growth Factor

   • Zhenping Zhu
   • Larry Witte

   OriginalPaper Pages: 195 - 212

2. Tyrosine Kinase Inhibitors in Preclinical Development

   • Mark L. Levitt
   • Patrick P. Koty

   OriginalPaper Pages: 213 - 226

3. Protein Kinase C Targeting in Antineoplastic Treatment Strategies

   • W. David Jarvis
   • Steven Grant

   OriginalPaper Pages: 227 - 240

4. Farnesyl Protein Transferase Inhibitors and Other Therapies Targeting the Ras Signal Transduction Pathway

   • David W. End

   OriginalPaper Pages: 241 - 258

5. Epidermal Growth Factor Receptor Inhibition in Cancer Therapy: Biology, Rationale and Preliminary Clinical Results

   • Shyh-Min Huang
   • Paul M. Harari

   OriginalPaper Pages: 259 - 269

6. Antiandrogens in Prostate Cancer

   • Phillip Reid
   • Philip Kantoff
   • William Oh

   OriginalPaper Pages: 271 - 284

7. Antiestrogens – Tamoxifen, SERMs and Beyond

   • Kapil Dhingra

   OriginalPaper Pages: 285 - 311

8. Flavopiridol: the First Cyclin-Dependent Kinase Inhibitor in Human Clinical Trials

   • Adrian M. Senderowicz

   OriginalPaper Pages: 313 - 320

9. Conference Announcement

   OriginalPaper Pages: 321 - 321